Michael Nagel is Director of Kiromic Biopharma, Inc.. Currently has a direct ownership of 43,296 shares of KRBP, which is worth approximately $38,966. The most recent transaction as insider was on Jun 11, 2024, when has been sold 1,000 shares (Common Stock) at a price of $3.33 per share, resulting in proceeds of $3,330. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.3K
0% 3M change
n/a 12M change
Total Value Held $38,966

MICHAEL NAGEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Open market or private purchase
$3,330 $3.33 p/Share
1,000 Added 2.26%
43,296 Common Stock
Mar 18 2024
BUY
Grant, award, or other acquisition
-
18,000 Added 29.85%
42,296 Restricted Stock Award
MN

Michael Nagel

Director
Houston, TX

Track Institutional and Insider Activities on KRBP

Follow Kiromic Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRBP shares.

Notify only if

Insider Trading

Get notified when an Kiromic Biopharma, Inc. insider buys or sells KRBP shares.

Notify only if

News

Receive news related to Kiromic Biopharma, Inc.

Track Activities on KRBP